NL8601051A - O-gesulfateerde beta-lactam-hydroxamzuren. - Google Patents

O-gesulfateerde beta-lactam-hydroxamzuren. Download PDF

Info

Publication number
NL8601051A
NL8601051A NL8601051A NL8601051A NL8601051A NL 8601051 A NL8601051 A NL 8601051A NL 8601051 A NL8601051 A NL 8601051A NL 8601051 A NL8601051 A NL 8601051A NL 8601051 A NL8601051 A NL 8601051A
Authority
NL
Netherlands
Prior art keywords
oxo
added
amino
solution
independently
Prior art date
Application number
NL8601051A
Other languages
English (en)
Dutch (nl)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NL8601051A publication Critical patent/NL8601051A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/12Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NL8601051A 1985-04-29 1986-04-24 O-gesulfateerde beta-lactam-hydroxamzuren. NL8601051A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/728,432 US4638060A (en) 1985-04-29 1985-04-29 O-sulfated spiro β-lactam hydroxamic acids
US72843285 1985-04-29

Publications (1)

Publication Number Publication Date
NL8601051A true NL8601051A (nl) 1986-11-17

Family

ID=24926831

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8601051A NL8601051A (nl) 1985-04-29 1986-04-24 O-gesulfateerde beta-lactam-hydroxamzuren.

Country Status (20)

Country Link
US (1) US4638060A (de)
JP (1) JPS61257965A (de)
AU (1) AU601944B2 (de)
BE (1) BE904699A (de)
CA (1) CA1273938A (de)
CH (1) CH668073A5 (de)
DE (1) DE3614317A1 (de)
DK (1) DK190286A (de)
ES (1) ES8800916A1 (de)
FI (1) FI861693A (de)
FR (1) FR2581062B1 (de)
GB (1) GB2174392B (de)
HU (1) HU194822B (de)
IE (1) IE59630B1 (de)
IT (1) IT1215652B (de)
NL (1) NL8601051A (de)
NZ (1) NZ215665A (de)
PT (1) PT82467B (de)
SE (1) SE8601963L (de)
ZA (1) ZA862429B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143913A (en) * 1988-04-04 1992-09-01 E. R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
US20140275007A1 (en) * 2013-03-14 2014-09-18 Rempex Pharmaceuticals, Inc. Oxamazin antibiotics
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
CN115463219A (zh) * 2021-11-09 2022-12-13 中国医学科学院医药生物技术研究所 包含β-内酰胺类化合物的药物组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260743A (en) * 1979-12-31 1981-04-07 Gist-Brocades N.V. Preparation of β-lactams and intermediates therefor
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
JPS586589A (ja) 1981-07-01 1983-01-14 Hitachi Ltd 論理回路
JPS58113174A (ja) * 1981-12-26 1983-07-05 Toyama Chem Co Ltd 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
JPS58194856A (ja) 1982-05-10 1983-11-12 Yamanouchi Pharmaceut Co Ltd 新規2−アゼチジノン誘導体

Also Published As

Publication number Publication date
ZA862429B (en) 1986-11-26
CA1273938C (en) 1990-09-11
CH668073A5 (fr) 1988-11-30
DE3614317A1 (de) 1986-11-06
BE904699A (fr) 1986-08-18
US4638060A (en) 1987-01-20
AU5556886A (en) 1986-11-06
NZ215665A (en) 1988-11-29
FR2581062A1 (fr) 1986-10-31
ES554438A0 (es) 1987-12-01
DK190286D0 (da) 1986-04-24
PT82467A (en) 1986-05-01
SE8601963L (sv) 1986-10-30
IE861067L (en) 1986-10-29
FR2581062B1 (fr) 1990-10-19
IE59630B1 (en) 1994-03-09
GB2174392B (en) 1988-11-09
HUT41384A (en) 1987-04-28
FI861693A (fi) 1986-10-30
SE8601963D0 (sv) 1986-04-28
IT8620227A0 (it) 1986-04-28
GB8609596D0 (en) 1986-05-21
JPS61257965A (ja) 1986-11-15
IT1215652B (it) 1990-02-22
CA1273938A (en) 1990-09-11
DK190286A (da) 1986-10-30
GB2174392A (en) 1986-11-05
PT82467B (pt) 1988-03-03
AU601944B2 (en) 1990-09-27
HU194822B (en) 1988-03-28
FI861693A0 (fi) 1986-04-22
ES8800916A1 (es) 1987-12-01

Similar Documents

Publication Publication Date Title
EP0051381B1 (de) 0-Sulfatierte beta-Lactamhydroxamsäuren
CA1246572A (en) 2-oxo-1-[[(substituted sulfonyl)amino]- carbonyl]azetidines
EP0303286A1 (de) 2-Oxo-1-[[(substituierte sulfonyl)amino]-carbonyl]-azetidine
EP0076758A2 (de) 4-Äther-Derivate von 2-Azetidinon-1-sulfonsäuren
NZ205111A (en) Beta-lactam derivatives
US4670553A (en) 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
EP0085291B1 (de) 2-Oxo-1-(aminocarbonylaminosulfonylaminocarbonyl)-azetidine
NL8601051A (nl) O-gesulfateerde beta-lactam-hydroxamzuren.
US4680388A (en) O-sulfated spiro β-lactam hydroxamic acids
EP0251143B1 (de) 2-Oxo-1-[[(substituiertes Sulfonyl)amino]-carbonyl]-Azetidine
US4534896A (en) 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
EP0229012A1 (de) Monosulfactame
EP0068466B1 (de) 4-Aryl- oder Heteroaryl-thio-2-oxo-1-azetidinsulfonsäuresalze und Verfahren zu deren Herstellung
US4533660A (en) Antibacterial O-sulfated β-lactam hydroxamic acids
CA1253502A (en) 4-[[(amidomethyl)oxy]methyl]-2-oxo-1- azetidinesulfonic acid salts
US4831130A (en) β-lactam antibacterial agents
EP0243924B1 (de) 2-Oxo-1-(substituierte phosphorigsäure)azetidine
NZ201523A (en) Beta-lactam antibiotic;2-oxo((acylamino)sulphonyl)azetidines
US4734496A (en) 4-amino derivatives of 2-oxo-1-azetidinesulfonic acid salts
EP0061763B1 (de) 4-Substituierte Mercapto-2-oxo-1-azetidinsulfonsäuresalze und Verfahren zu ihrer Herstellung
GB2103212A (en) 4-Substituted derivatives of 2-oxo-1-azatidinesulfonic acid salts
GB2129428A (en) Azetidinyl sulfonic acid and analogs
US4912214A (en) Isothiazolyl beta-lactam antibacterial agents
CA1243679A (en) 3-ACYLAMINO-2-OXO-1-AZETIDINYL-.beta.-OXYPROPIONATES
CA1268763A (en) 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed